Pharming Group (PHAR)
9.725
-0.28
(-2.75%)
USD |
NASDAQ |
May 06, 16:00
9.93
+0.20
(+2.11%)
After-Hours: 20:00
Pharming Group Cash from Investing (TTM): -129.39M for Dec. 31, 2023
Cash from Investing (TTM) Chart
Historical Cash from Investing (TTM) Data
Date | Value |
---|---|
December 31, 2023 | -129.39M |
September 30, 2023 | -125.88M |
June 30, 2023 | 19.40M |
March 31, 2023 | 5.483M |
December 31, 2022 | 5.323M |
September 30, 2022 | -0.406M |
June 30, 2022 | -7.56M |
March 31, 2022 | -19.12M |
December 31, 2021 | -21.30M |
September 30, 2021 | -18.88M |
June 30, 2021 | -12.99M |
March 31, 2021 | -11.27M |
December 31, 2020 | -15.63M |
September 30, 2020 | -15.28M |
June 30, 2020 | -33.80M |
March 31, 2020 | -34.80M |
December 31, 2019 | -28.26M |
September 30, 2019 | -24.70M |
June 30, 2019 | -6.804M |
March 31, 2019 | -3.624M |
December 31, 2018 | -4.311M |
September 30, 2018 | -6.237M |
June 30, 2018 | -7.23M |
March 31, 2018 | -7.434M |
December 31, 2017 | -7.252M |
Date | Value |
---|---|
September 30, 2017 | -64.94M |
June 30, 2017 | -61.96M |
March 31, 2017 | -61.06M |
December 31, 2016 | -60.45M |
September 30, 2016 | -1.269M |
June 30, 2016 | -1.363M |
March 31, 2016 | -1.194M |
December 31, 2015 | -0.9818M |
September 30, 2015 | -0.908M |
June 30, 2015 | -1.251M |
March 31, 2015 | -0.8548M |
December 31, 2014 | -0.7953M |
September 30, 2014 | -0.6269M |
June 30, 2014 | 0.0193M |
March 31, 2014 | -0.0027M |
December 31, 2013 | 0.3328M |
September 30, 2013 | 0.3281M |
June 30, 2013 | 1.183M |
March 31, 2013 | 0.6398M |
December 31, 2012 | 0.1428M |
September 30, 2012 | -0.4003M |
June 30, 2012 | -1.288M |
March 31, 2012 | -1.337M |
December 31, 2011 | -1.423M |
September 30, 2011 | -1.165M |
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (TTM) Range, Past 5 Years
-129.39M
Minimum
Dec 2023
19.40M
Maximum
Jun 2023
-25.04M
Average
-15.63M
Median
Dec 2020
Cash from Investing (TTM) Benchmarks
uniQure NV | -205.69M |
ProQR Therapeutics NV | 4.631M |
Merus NV | -27.02M |
argenx SE | -- |
Pharvaris NV | -0.0974M |